mhurhangee/ep-ind-claims huggingface dataset:
A valve actuator comprising moving equipment arranged to cause a plug of said equipment to slide along a given axis between two end positions, making it possible in service for the plug to put an admission channel of the valve into communication with at least one outlet of said valve, the moving equipment comprising a core constrained to move in translation with the plug along the given axis, the actuator including a coil lying between two rings (29, 30) of ferromagnetic material, all three of which are secured to a frame of the actuator so as to surround the core, which itself carries two magnets (23, 24) mounted in opposition on the core level with the coil, The valve actuator being characterized in that a ring of ferromagnetic material lies between the two magnets that also lie between two other rings (25, 27) of ferromagnetic material, applying power to the coil causing one of the magnets carried by the core to be attracted and the other magnet to be repelled depending on the direction in which the coil is powered, co-operation between the pair of rings of the frame and a respective one of the pairs of rings of the core serving to lock the plug in each of its end positions when the coil ceases to be powered, the moving equipment also having at least two elastically deformable elements (15, 22) connected to the core in such a manner that the pairs of rings of the core are offset from the pair of rings of the frame while locking the plug in each of its end positions.
A mobile charging station for electrical charging of electric vehicles, comprising at least one battery unit, at least one first charging interface for charging the battery unit, at least one second interface for charging an electric vehicle from the battery unit, means for automatic navigation of the mobile charging station and means for receiving a charging request, characterized in that the mobile charging station has a mobile robot platform and a passive platform with wheels that are mechanically couplable to one another, wherein the mobile robot platform has at least one electrical drive, which is supplied with power by a further battery unit, wherein the battery unit for charging an electric vehicle is arranged on the passive platform.
A method for producing a silicon compound shown by the following general formula through a hydrosilylation reaction between a hydrosilane compound shown by the following general formula and a carbonyl group-containing alicyclic olefin compound shown by the following general formula, wherein the hydrosilylation reaction between the hydrosilane compound shown by the following general formula and the carbonyl group-containing alicyclic olefin compound shown by the following general formula takes place while an acidic compound or acidic compound precursor is gradually added thereto in presence of a platinum-based catalyst: wherein R 1 and R 2 each independently represent a hydrocarbon group having 1 to 6 carbon atoms; "n" represents 1, 2, or 3; X 1 represents an oxygen atom or a single bond; X 2 represents a methylene group or an oxygen atom; R 3 and R 4 each independently represent a hydrogen atom or a methyl group; and R 5 represents a monovalent group having 1 to 20 carbon atoms and is optionally bonded to R 3 or R 4 to form a ring.
A multifunctional measuring device wherein it comprises - a housing with an aperture for passing a primary current conductor through, - an inner winding, accommodated around said aperture inside of said housing, the inner winding forming a first measuring element for a measurement of a current in the primary current conductor, the inner winding comprising a return conductor for reducing effects of stray magnetic fields, characterized in that the measuring device further comprises - an external winding wound on said housing around said aperture, the external winding forming a second measuring element for another current measurement in the primary current conductor, while the first measuring element has different parameters, ratings or accuracy than the second measuring element. - a housing with an aperture for passing a primary current conductor through, - an inner winding, accommodated around said aperture inside of said housing, the inner winding forming a first measuring element for a measurement of a current in the primary current conductor, the inner winding comprising a return conductor for reducing effects of stray magnetic fields, characterized in that the measuring device further comprises - an external winding wound on said housing around said aperture, the external winding forming a second measuring element for another current measurement in the primary current conductor, while the first measuring element has different parameters, ratings or accuracy than the second measuring element.
A method of removing fluid from a subsea wellbore and subsea wellhead assembly, the wellbore being in fluid communication with a producing formation, but containing a non-production fluid that impedes natural flow from the producing formation, the method comprising: a) providing a pressurizing module comprising a pressurizing device with an entrance and an exit, a suction line having an end coupled to the entrance of the pressurizing device and a discharge line having an end coupled to the exit of the pressurizing device; b) coupling the pressurizing module with the wellhead assembly so that the suction line is in fluid communication with the non-production fluid in the wellbore; c) activating the pressurizing device to draw the non-production fluid from the wellbore, through the suction line, through the pressurizing device, and into the discharge line; d) when a sufficient amount of the non-production fluid is withdrawn so that the production fluid is flowing naturally, deactivating the pressurizing device; and e) disconnecting the pressurizing device from the wellhead assembly, relocating the pressurizing module to another subsea wellhead assembly, and repeating steps (b), (c), and (d). a) providing a pressurizing module comprising a pressurizing device with an entrance and an exit, a suction line having an end coupled to the entrance of the pressurizing device and a discharge line having an end coupled to the exit of the pressurizing device; b) coupling the pressurizing module with the wellhead assembly so that the suction line is in fluid communication with the non-production fluid in the wellbore; c) activating the pressurizing device to draw the non-production fluid from the wellbore, through the suction line, through the pressurizing device, and into the discharge line; d) when a sufficient amount of the non-production fluid is withdrawn so that the production fluid is flowing naturally, deactivating the pressurizing device; and e) disconnecting the pressurizing device from the wellhead assembly, relocating the pressurizing module to another subsea wellhead assembly, and repeating steps (b), (c), and (d).
Audio rendering system, comprising: a plurality of loudspeakers arranged to produce a sound field that approximates a desired spatial sound field within a predetermined reproduction region, wherein the loudspeakers are configured to produce the sound field based on a weighted series of orthonormal basis functions for the reproduction region by choosing positions of the loudspeakers and signals and gains applied to the loudspeakers, wherein the weights of the weighted series are adjusted by determining a weighted least squares solution of the weighted series of orthonormal basis functions with respect to the desired sound field, wherein the spatial sound field comprises at least one bright zone and at least one quiet zone, wherein the bright zone is a zone of the reproduction region with a maximum acoustic energy and the quiet zone is a zone of the reproduction region with a minimum acoustic energy, wherein a weighting function of the weighted least squares solution depends on the at least one bright zone, the at least one quiet zone and a remaining unattended zone in the desired reproduction region, wherein the remaining unattended zone is a transition zone between the bright zone and the quiet zone, and the weighting function reads: w x = { a, x ∈ the bright zone b, x ∈ the quiet zone c, x ∈ t h e u n a t t e n d e d z one with a, b and c being weights and x denotes a spatial observation point. a plurality of loudspeakers arranged to produce a sound field that approximates a desired spatial sound field within a predetermined reproduction region, wherein the loudspeakers are configured to produce the sound field based on a weighted series of orthonormal basis functions for the reproduction region by choosing positions of the loudspeakers and signals and gains applied to the loudspeakers, wherein the weights of the weighted series are adjusted by determining a weighted least squares solution of the weighted series of orthonormal basis functions with respect to the desired sound field, wherein the spatial sound field comprises at least one bright zone and at least one quiet zone, wherein the bright zone is a zone of the reproduction region with a maximum acoustic energy and the quiet zone is a zone of the reproduction region with a minimum acoustic energy, wherein a weighting function of the weighted least squares solution depends on the at least one bright zone, the at least one quiet zone and a remaining unattended zone in the desired reproduction region, wherein the remaining unattended zone is a transition zone between the bright zone and the quiet zone, and the weighting function reads: w x = { a, x ∈ the bright zone b, x ∈ the quiet zone c, x ∈ t h e u n a t t e n d e d z one with a, b and c being weights and x denotes a spatial observation point.
An operating table column, comprising a base member and comprising a column head on top of which a patient support unit can be secured, wherein the operating table column comprises a first linear actuator and a second linear actuator, which are independently adjustable for changing the position of the column head relative to the base member, wherein the first linear actuator and the second linear actuator are each oriented and arranged so as to perform a positioning movement in a vertical direction upon activation, wherein the first linear actuator is mechanically connected to the column head via a first connecting area and the second linear actuator is mechanically connected to the column head via a second connecting area, wherein the column head comprises a length adjustment assembly (36, 50), by means of which the distance between the first connecting area and the second connecting area can be adjusted during a positioning movement of the first linear actuator and/or the second linear actuator, wherein the first linear actuator and the second linear actuator are the only force transmitting elements between the column head and the base member, wherein the column head and the upper end of the first linear actuator are mechanically connected within the first connecting area via a first pivot bearing so as to be pivotable about a first rotational axis, wherein the column head and the upper end of the second linear actuator are mechanically connected within the second connecting area via a second pivot bearing so as to be pivotable about a second rotational axis, and wherein the first rotational axis and the second rotational axis are parallel, characterized in that the column head has at least one first support element, which is fixedly connected to the first pivot bearing and is pivotable about the first rotational axis, wherein the first support element has at least one third connecting area for connecting a first end of a third linear actuator, and wherein a second end, opposite the first end, of the third linear actuator is operatively connected to the patient support unit interface of the column head.
A protein comprising one or more fragments of SEQ ID NO: 2918 of WO99/57280 (MKKIIFAALAAAAISTASAATYKVDEYHANARFAIDHFNTSTNVG GFYGLTGSVEFDQAKRDGKIDITIPIANLQSGSQHFTDHLKSADIFDAAQYPDIRFVSTKFNFN GKKLVSVDGNLTMHGKTAPVKLKAEKFNCYQSPMEKTEVCGGDFSTTIDRTKWGMDYLV NVGMTKSVRIDIQIEAAKQ), wherein said fragment(s): (a) comprise at least one antigenic determinant; and (b) comprise a sequence selected from: and wherein said protein is not SEQ ID NOs: 2916, 2918, or 2920 of WO99/57280 (a) comprise at least one antigenic determinant; and (b) comprise a sequence selected from: and wherein said protein is not SEQ ID NOs: 2916, 2918, or 2920 of WO99/57280
A radio base station that receives from a radio communication terminal an uplink radio signal including a known signal, in a radio communication system that uses an orthogonal frequency division multiplexing; wherein the known signal is used for estimating quality of a radio resource in the uplink by the radio base station, and arranged in a frequency axial direction, wherein the known signal is arranged at a location fixed within a sub-frame in a time axial direction, and the radio base station comprises notification means that notifies the radio communication terminal of signal configuration designation information including an element relating to a bandwidth of the known signal in the frequency axial direction, the element being indicating the number of frequency bands where a predetermined number of subcarriers are one unit.
A method for automatic message generation in a wireless M-Bus based communication system, the system comprising a master and at least one slave; an address register with a related flag register; an intelligent message generator consisting of a mailbox where several pre-generated messages, which are unique messages for a specific slave, or templates, where the address is open, are stored, and a message generator which generates standard messages; the method further comprising, in the master: registering all slaves in the address register, receiving a message from a slave, using the address register to search and find the slave and the flag register to see if a message shall be generated and transmitted to the slave, wherein the flag register comprises flags for selecting which standard message shall be transmitted, or pointers pointing to one or more mailboxes, transmitting to the slave either a standard message generated by the message generator or a message generated from the mailbox. a mailbox where several pre-generated messages, which are unique messages for a specific slave, or templates, where the address is open, are stored, and a message generator which generates standard messages; the method further comprising, in the master: registering all slaves in the address register, receiving a message from a slave, using the address register to search and find the slave and the flag register to see if a message shall be generated and transmitted to the slave, wherein the flag register comprises flags for selecting which standard message shall be transmitted, or pointers pointing to one or more mailboxes, transmitting to the slave either a standard message generated by the message generator or a message generated from the mailbox. registering all slaves in the address register, receiving a message from a slave, using the address register to search and find the slave and the flag register to see if a message shall be generated and transmitted to the slave, wherein the flag register comprises flags for selecting which standard message shall be transmitted, or pointers pointing to one or more mailboxes, transmitting to the slave either a standard message generated by the message generator or a message generated from the mailbox.
An isolated human or humanised antibody or an immunologically active fragment thereof that immunospecifically binds to a human Hepatitis A Virus cellular receptor I (HAVcr-1) polypeptide comprising a sequence selected from SEQID NO: 2, 4, 6, 8 and 39 for use in treating cancer in a subject selected from lung cancer and ovarian cancer, wherein said antibody or fragment binds the HAVcr-1 polypeptide with an equilibrium dissociation constant that is less than or equal to 100 nM and wherein the antibody or immunologically active fragment thereof is conjugated to a cytotoxic agent selected from the group consisting of a chemotherapeutic agent, a toxin, and a radioactive isotope.
Power-driven hand-tool comprising a housing, a work spindle for driving a tool, wherein the tool can be fixed between a tool-facing end of the work spindle and a tension shaft by means of a clamping element, and further comprising a displacing device for displacing the tension shaft between a clamping position within which the clamping element is biased against the tool-facing end of the work spindle by means of a biasing spring, and between a released position within which the clamping element can be detached from the tension shaft, wherein the work spindle can be driven oscillatingly about its longitudinal axis, wherein the displacing device comprises an activating lever which is fixed in the clamping position by means of a spring element against a stop at the housing, and which is biased in the released position against the spring element, wherein the activating lever is received pivotably about a pivot axis on the housing and comprises a gripping region for applying an activating force and comprises a counter profile which is configured for cooperating with a contact surface of the tension shaft for displacing the tension shaft in the direction of the longitudinal axis, and wherein the pivot axis is arranged perpendicular to the longitudinal axis, characterized in that the activating lever is pivotable in the direction of the tool-facing end of the tension shaft by means of pressure applied onto the gripping region.
A process for producing a population of cells which comprises mature atrial cardiomyocytes, the process comprising the step: (a) treating a first population of cells according to a treatment regimen, wherein the first population of cells comprises iPS cells, wherein the treatment regimen comprises: (i) culturing the first population of cells in a first cardiac cell differentiation medium which comprises a GSK3B inhibitor between Day 0 and Day 2; (ii) culturing the population of cells from step (i) in a second cardiac cell differentiation medium which comprises a WNT inhibitor between Day 2 and Day 4; (iii) culturing the population of cells from step (ii) in a third cardiac cell differentiation medium comprising Gremlin2 at a concentration of 0.1 to 10 μg/ml between Day 4 and Day 6; and (iv) culturing the population of cells from step (iii) in a fourth cardiac cell differentiation medium comprising retinoic acid at a concentration of 0.1 to 10 μM between Day 6 and Day 10, such that at least a portion of the iPS cells in the first population of cells differentiate into mature atrial cardiomyocytes, thereby producing a second population of cells which comprises mature atrial cardiomyocytes. (a) treating a first population of cells according to a treatment regimen, wherein the first population of cells comprises iPS cells, wherein the treatment regimen comprises: (i) culturing the first population of cells in a first cardiac cell differentiation medium which comprises a GSK3B inhibitor between Day 0 and Day 2; (ii) culturing the population of cells from step (i) in a second cardiac cell differentiation medium which comprises a WNT inhibitor between Day 2 and Day 4; (iii) culturing the population of cells from step (ii) in a third cardiac cell differentiation medium comprising Gremlin2 at a concentration of 0.1 to 10 μg/ml between Day 4 and Day 6; and (iv) culturing the population of cells from step (iii) in a fourth cardiac cell differentiation medium comprising retinoic acid at a concentration of 0.1 to 10 μM between Day 6 and Day 10, (i) culturing the first population of cells in a first cardiac cell differentiation medium which comprises a GSK3B inhibitor between Day 0 and Day 2; (ii) culturing the population of cells from step (i) in a second cardiac cell differentiation medium which comprises a WNT inhibitor between Day 2 and Day 4; (iii) culturing the population of cells from step (ii) in a third cardiac cell differentiation medium comprising Gremlin2 at a concentration of 0.1 to 10 μg/ml between Day 4 and Day 6; and (iv) culturing the population of cells from step (iii) in a fourth cardiac cell differentiation medium comprising retinoic acid at a concentration of 0.1 to 10 μM between Day 6 and Day 10,
A medical device for supporting and stabilizing a head of a patient during a medical procedure, wherein the medical device is configured to connect with an operating table directly or indirectly via one or more intermediate structures, wherein the medical device comprises: (a) a central head support configured to provide subjacent support to the head of the patient; (b) a cushion connectable with the central head support, wherein the cushion is configured to contact the head of the patient, wherein the cushion comprises: (i) a first chamber configured to receive a select one of a first fluid and a first shape-conforming material; (c) two or more lateral head supports, wherein each of the two or more lateral head supports is configured to provide lateral support to the head of the patient; and (d) two or more pads configured to contact the head of the patient, wherein each of the two or more pads is connectable with a respective one of the two or more lateral head supports, wherein each of the two or more pads comprises: (i) a second chamber configured to receive a second fluid, and (ii) a third chamber configured to receive a second shape-conforming material. (a) a central head support configured to provide subjacent support to the head of the patient; (b) a cushion connectable with the central head support, wherein the cushion is configured to contact the head of the patient, wherein the cushion comprises: (i) a first chamber configured to receive a select one of a first fluid and a first shape-conforming material; (i) a first chamber configured to receive a select one of a first fluid and a first shape-conforming material; (c) two or more lateral head supports, wherein each of the two or more lateral head supports is configured to provide lateral support to the head of the patient; and (d) two or more pads configured to contact the head of the patient, wherein each of the two or more pads is connectable with a respective one of the two or more lateral head supports, wherein each of the two or more pads comprises: (i) a second chamber configured to receive a second fluid, and (ii) a third chamber configured to receive a second shape-conforming material. (i) a second chamber configured to receive a second fluid, and (ii) a third chamber configured to receive a second shape-conforming material.
Method of preserving a water treatment system with a brine, wherein the water treatment system comprises a container in which at least one water treatment structure is arranged, and wherein the water treatment system remains in a preservation state for a preservation time t1 of at least 8 hours, in particular wherein the preservation state is terminated by rinsing the container with water prior to a start-up of the water treatment system, characterized in that in the preservation state a surface of the at least one water treatment structure in the container is kept wetted with the brine, and a surrounding area of the at least one water treatment structure in the container is kept filled with a gas. wherein the water treatment system comprises a container in which at least one water treatment structure is arranged, and wherein the water treatment system remains in a preservation state for a preservation time t1 of at least 8 hours, in particular wherein the preservation state is terminated by rinsing the container with water prior to a start-up of the water treatment system, characterized in that in the preservation state a surface of the at least one water treatment structure in the container is kept wetted with the brine, and a surrounding area of the at least one water treatment structure in the container is kept filled with a gas.